Market Cap (In SEK)
344.66 Million
Revenue (In SEK)
29.32 Million
Net Income (In SEK)
-76.39 Million
Avg. Volume
437.59 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.6-3.15
- PE
- -
- EPS
- -
- Beta Value
- 1.766
- ISIN
- SE0007074166
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. David Westberg
- Employee Count
- -
- Website
- https://www.nanexa.com
- Ipo Date
- 2015-06-17
- Details
- Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
More Stocks
-
JSPT
-
FLM
-
WKGFFWestKam Gold Corp.
WKGFF
-
URCFFVanadian Energy Corp.
URCFF
-
156AMATERIAL GROUP INC
156A
-
CPIHF
-
2163Artner Co.,Ltd.
2163
-
3056